JPH03505448A - 遅延放出性製剤 - Google Patents
遅延放出性製剤Info
- Publication number
- JPH03505448A JPH03505448A JP1505660A JP50566089A JPH03505448A JP H03505448 A JPH03505448 A JP H03505448A JP 1505660 A JP1505660 A JP 1505660A JP 50566089 A JP50566089 A JP 50566089A JP H03505448 A JPH03505448 A JP H03505448A
- Authority
- JP
- Japan
- Prior art keywords
- amylose
- vitreous
- active compound
- composition
- colon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
Abstract
Description
Claims (15)
- 1.有効化合物およびガラス質アミロースからなり、ガラス質アミロースがpH 1〜9の水性環境で37℃において組成物からの有効成分の放出を遲延させ、ア ミロースを開製しうる酵素に暴露された際には有効成分の放出を可能にする、遅 延放出性組成物。
- 2.ガラス質アミロースで被覆された有効化合物からなる遅延放出性組成物。
- 3.ガラス質アミロースと混合された有効化合物からなり、粉末状またはモノリ ス状である、遅延放出性組成物。
- 4.生理学的に有効な化合物およびガラス質アミロースからなり、有効化合物が 組成物の経口投与後に結腸内へ選択的に放出される薬剤組成物。
- 5.生理学的に有効な化合物およびガラス質アミロースからなる、治療用または 診断用組成物。
- 6.有効化合物が結腸の疾患を治療するための医薬である、請求の範囲第1項な いし第5項のいずれかに記載の組成物。
- 7.ガラス質アミロース被膜を有する有効化合物からなる遅延放出性組成物の製 造方法において、アミロースを有効化合物上に水溶液として吹付け、次いで乾燥 させるか、またはガラス質アミロースを溶融し、これを有効化合物に塗布し、そ して冷却することよりなる方法。
- 8.有効化合物およびガラス質アミロースからなる遅延放出性組成物の製造方法 において、ガラス質アミロースの粒子および有効化合物の粒子を一緒に圧縮する ことよりなる方法。
- 9.有効化合物およびガラス質アミロースからなる遅延放出性組成物の製造方法 において、有効化合物およびアミロースの液体混合物を調製し、次いでこの液体 混合物をガラス質アミロースを含有する固体組成物に転化することよりなる方法 。
- 10.有効成分が医薬である、請求の範囲第7項、第8項または第9項に記載の 方法。
- 11.医薬が結腸の疾患を治療するためのものである、請求の範囲第10項に記 載の方法。
- 12.結腸疾患治療用薬剤の製造を目的とした該疾患の治療に有効な化合物およ びガラス質アミロースの使用。
- 13.結腸疾患診断用の診断剤の製造を目的とした該疾患の診断に有用な化合物 およびガラス質アミロースの使用。
- 14.結腸疾患の治療を必要とする患者に、該疾患の治療に用いられる薬剤およ びガラス質アミロースからなる組成物を、治療に有効な量投与することよりなる 該疾患の治療方法。
- 15.疾患が潰瘍性結腸炎、クローン病または癌である、請求の範囲第12項も しくは第13項に記載の使用、または第14項に記載の方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB888812490A GB8812490D0 (en) | 1988-05-26 | 1988-05-26 | Delayed release formulations |
GB8812490.4 | 1988-05-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH03505448A true JPH03505448A (ja) | 1991-11-28 |
JP2898036B2 JP2898036B2 (ja) | 1999-05-31 |
Family
ID=10637578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1505660A Expired - Lifetime JP2898036B2 (ja) | 1988-05-26 | 1989-05-25 | 遅延放出性製剤 |
Country Status (13)
Country | Link |
---|---|
US (1) | US5108758A (ja) |
EP (1) | EP0343993B1 (ja) |
JP (1) | JP2898036B2 (ja) |
AT (1) | ATE75936T1 (ja) |
CA (1) | CA1339081C (ja) |
DE (1) | DE68901494D1 (ja) |
DK (1) | DK175257B1 (ja) |
ES (1) | ES2037422T3 (ja) |
FI (1) | FI99085C (ja) |
GB (2) | GB8812490D0 (ja) |
GR (1) | GR3004604T3 (ja) |
NO (1) | NO179274C (ja) |
WO (1) | WO1989011269A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017095507A (ja) * | 2006-04-13 | 2017-06-01 | ユニバーシティ カレッジ ロンドン | 結腸薬物送達製剤 |
Families Citing this family (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484605A (en) * | 1988-11-25 | 1996-01-16 | Henning Berlin Gmbh Chemie-Und Pharmawerk | Agent for treating chronically inflammatory intestinal diseases |
US5468286A (en) * | 1989-10-25 | 1995-11-21 | National Starch And Chemical Investment Holding Corporation | Enzymatically debranched starches as tablet excipients |
GB8926639D0 (en) * | 1989-11-24 | 1990-01-17 | Agricultural & Food Res | Delayed release formulations |
IL98087A (en) * | 1990-05-04 | 1996-11-14 | Perio Prod Ltd | Preparation for dispensing drugs in the colon |
CA2041774C (en) * | 1990-11-27 | 1994-04-19 | Mircea A. Mateescu | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds |
US5603956A (en) * | 1990-11-27 | 1997-02-18 | Labopharm Inc. | Cross-linked enzymatically controlled drug release |
CA2032385A1 (en) * | 1990-12-17 | 1992-06-18 | Chung Wai-Chiu | Enzymatically debranched starches as tablet excipients |
DE4120918A1 (de) * | 1991-06-25 | 1993-01-07 | Basf Ag | Pulverfoermige praeparate aus einer wasserunloeslichen kernsubstanz und einer schutzhuelle |
NL9201195A (nl) * | 1992-07-03 | 1994-02-01 | Tno | Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat. |
US5616343A (en) * | 1993-03-25 | 1997-04-01 | Labopharm, Inc. | Cross-linked amylose as a binder/disintegrant in tablets |
IT1265092B1 (it) * | 1993-05-31 | 1996-10-30 | Giuliani Spa | Preparato per uso come integratore alimentare, o dietetico,a rilascio mirato nel colon |
US5514663A (en) * | 1993-10-19 | 1996-05-07 | The Procter & Gamble Company | Senna dosage form |
US6028190A (en) | 1994-02-01 | 2000-02-22 | The Regents Of The University Of California | Probes labeled with energy transfer coupled dyes |
GB9412394D0 (en) | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
US5691343A (en) * | 1995-03-30 | 1997-11-25 | Mayo Foundation For Medical Education And Research | Use of topical azathioprine to treat inflammatory bowel disorders |
US6166024A (en) * | 1995-03-30 | 2000-12-26 | Mayo Foundation For Medical Education And Research | Use of topical azathioprine and thioguanine to treat colorectal adenomas |
US5811388A (en) * | 1995-06-07 | 1998-09-22 | Cibus Pharmaceutical, Inc. | Delivery of drugs to the lower GI tract |
US5656294A (en) * | 1995-06-07 | 1997-08-12 | Cibus Pharmaceutical, Inc. | Colonic delivery of drugs |
GB9516268D0 (en) | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
ES2196149T3 (es) * | 1996-05-08 | 2003-12-16 | Craig A Aronchick | Preparaciones purgantes no acuosas para el colon. |
US5879707A (en) * | 1996-10-30 | 1999-03-09 | Universite De Montreal | Substituted amylose as a matrix for sustained drug release |
US6162464A (en) * | 1997-03-31 | 2000-12-19 | Inkine Pharmaceutical, Inc. | Non-aqueous colonic purgative formulations |
US6056954A (en) | 1997-10-31 | 2000-05-02 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymers for the prophylactic and therapeutic treatment of various illnesses |
US6406692B1 (en) * | 1997-10-31 | 2002-06-18 | New Horizons Diagnostics Corp | Composition for treatment of an ocular bacterial infection |
US6752988B1 (en) | 2000-04-28 | 2004-06-22 | New Horizons Diagnostic Corp | Method of treating upper resiratory illnesses |
US6432444B1 (en) | 1997-10-31 | 2002-08-13 | New Horizons Diagnostics Corp | Use of bacterial phage associated lysing enzymes for treating dermatological infections |
US6423299B1 (en) | 1997-10-31 | 2002-07-23 | Vincent Fischetti | Composition for treatment of a bacterial infection of an upper respiratory tract |
US20030082110A1 (en) * | 1997-10-31 | 2003-05-01 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US20030129146A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | The use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US6428784B1 (en) * | 1997-10-31 | 2002-08-06 | New Horizons Diagnostics Corp | Vaginal suppository for treating group B Streptococcus infection |
US20030129147A1 (en) * | 1997-10-31 | 2003-07-10 | Vincent Fischetti | Use of bacterial phage associated lysing proteins for treating bacterial dental caries |
US7232576B2 (en) | 1997-10-31 | 2007-06-19 | New Horizons Diagnostics Corp | Throat lozenge for the treatment of Streptococcus Group A |
US6277399B1 (en) | 1997-10-31 | 2001-08-21 | New Horizon Diagnostics Corporation | Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
US20020136712A1 (en) * | 1997-10-31 | 2002-09-26 | Fischetti Vincent | Bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of colonization and infections caused by streptococcus pneumoniae |
GB9724186D0 (en) * | 1997-11-14 | 1998-01-14 | British Tech Group | Low temperature coatings |
DE19820529A1 (de) * | 1998-05-08 | 1999-11-11 | Lohmann Therapie Syst Lts | Wirkstoff enthaltende orale und mucosale Zubereitung mit steuerbarer Wirkstofffreisetzung und ihre Verwendung |
US7063837B2 (en) * | 1999-09-14 | 2006-06-20 | New Horizons Diagnostics Corp | Syrup composition containing phage associated lytic enzymes |
US6607748B1 (en) | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
EP1174127A1 (en) * | 2000-07-21 | 2002-01-23 | Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno | Composition for targeted release of an actvie substance and process for producing such a composition |
WO2002102405A1 (en) * | 2000-11-02 | 2002-12-27 | New Horizons Diagnostics Corporation | The use of bacterial phage associated lytic enzymes to prevent food poisoning |
US20040213765A1 (en) * | 2001-07-13 | 2004-10-28 | Vincent Fischetti | Use of bacterial phage associated lytic enzymes to prevent food poisoning |
WO2005048998A1 (en) * | 2003-11-21 | 2005-06-02 | Commonwealth Scientific & Industrial Research Organisation | G i tract delivery systems |
WO2005065291A2 (en) * | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
WO2005105851A1 (en) * | 2004-04-28 | 2005-11-10 | Commonwealth Scientific & Industrial Research Organisation | Starch treatment process |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
US7879802B2 (en) | 2007-06-04 | 2011-02-01 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3239170B1 (en) | 2008-06-04 | 2019-03-20 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
EP3241839B1 (en) | 2008-07-16 | 2019-09-04 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders |
ES2586135T3 (es) | 2010-02-23 | 2016-10-11 | Da Volterra | Formulaciones para el suministro oral de adsorbentes en el intestino |
JP6005636B2 (ja) | 2010-07-06 | 2016-10-12 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Gaba類似体及びオピオイドを含む新規胃内滞留型剤形 |
EP2425826A1 (en) * | 2010-09-01 | 2012-03-07 | Disphar International B.V. | Mesalazine tablet having improved dissolution |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
CA3107450A1 (en) | 2012-03-29 | 2013-10-03 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
HUE036187T2 (hu) | 2012-04-30 | 2018-06-28 | Tillotts Pharma Ag | Késleltetett leadású gyógyszerkészítmény |
US9545446B2 (en) | 2013-02-25 | 2017-01-17 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
JP6464142B2 (ja) | 2013-03-14 | 2019-02-06 | セラバイオーム,エルエルシー | プロバイオティクス生物及び/又は治療剤の標的化胃腸管デリバリー |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
EP3054969B1 (en) | 2013-10-10 | 2021-03-10 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of opioid induced dysfunctions |
UA117260C2 (uk) | 2013-10-29 | 2018-07-10 | Тиллоттс Фарма АГ | Лікарський препарат з відстроченим вивільненням |
AR101476A1 (es) | 2014-08-07 | 2016-12-21 | Acerta Pharma Bv | Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk) |
EP3359158A4 (en) | 2015-09-29 | 2019-05-08 | Prodrugxtend PTY Ltd | FORMULATIONS AND METHODS OF TREATMENT NEWS |
JP2019506383A (ja) | 2016-01-11 | 2019-03-07 | シナジー ファーマシューティカルズ インコーポレイテッド | 潰瘍性大腸炎を治療するための製剤および方法 |
EP3662900A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Colonic drug delivery formulation |
EP3662902A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Colonic drug delivery formulation |
EP3662898A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Solid composition comprising mesalazine |
EP3662901A1 (en) | 2018-12-07 | 2020-06-10 | Tillotts Pharma AG | Delayed release drug formulation comprising an outerlayer with an enzymaticyaaly degradable polymer, its composition and its method of manufacturing |
WO2022101269A1 (en) | 2020-11-13 | 2022-05-19 | Da Volterra | Formulations and dosage regimen for oral delivery of adsorbents in the gut |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1072795A (en) * | 1963-08-28 | 1967-06-21 | Eastman Kodak Co | Solid composition containing fat-soluble vitamins and processes for making it |
US3499962A (en) * | 1967-08-24 | 1970-03-10 | Nat Starch Chem Corp | Encapsulation of water insoluble materials |
BG46154A3 (en) * | 1983-02-18 | 1989-10-16 | Warner Lambert Co | Method for preparing of capsules |
JPS6124516A (ja) * | 1984-07-12 | 1986-02-03 | Fujisawa Pharmaceut Co Ltd | 持続性錠剤 |
US4755397A (en) * | 1986-12-24 | 1988-07-05 | National Starch And Chemical Corporation | Starch based particulate encapsulation process |
US4911952A (en) * | 1987-07-10 | 1990-03-27 | The United States Of America As Represented By The Secretary Of Agriculture | Encapsulation by entrapment within matrix of unmodified starch |
KR100585099B1 (ko) * | 2003-08-13 | 2006-05-30 | 삼성전자주식회사 | 적층형 메모리 모듈 및 메모리 시스템. |
-
1988
- 1988-05-26 GB GB888812490A patent/GB8812490D0/en active Pending
-
1989
- 1989-05-25 US US07/438,488 patent/US5108758A/en not_active Expired - Lifetime
- 1989-05-25 JP JP1505660A patent/JP2898036B2/ja not_active Expired - Lifetime
- 1989-05-25 DE DE8989305318T patent/DE68901494D1/de not_active Expired - Lifetime
- 1989-05-25 GB GB8912048A patent/GB2220350B/en not_active Revoked
- 1989-05-25 WO PCT/GB1989/000581 patent/WO1989011269A1/en active IP Right Grant
- 1989-05-25 AT AT89305318T patent/ATE75936T1/de not_active IP Right Cessation
- 1989-05-25 EP EP89305318A patent/EP0343993B1/en not_active Expired - Lifetime
- 1989-05-25 CA CA000600598A patent/CA1339081C/en not_active Expired - Fee Related
- 1989-05-25 ES ES89305318T patent/ES2037422T3/es not_active Expired - Lifetime
-
1990
- 1990-01-25 DK DK199000202A patent/DK175257B1/da not_active IP Right Cessation
- 1990-01-25 FI FI900410A patent/FI99085C/fi not_active IP Right Cessation
- 1990-01-25 NO NO900356A patent/NO179274C/no not_active IP Right Cessation
-
1992
- 1992-05-14 GR GR920400904T patent/GR3004604T3/el unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2017095507A (ja) * | 2006-04-13 | 2017-06-01 | ユニバーシティ カレッジ ロンドン | 結腸薬物送達製剤 |
Also Published As
Publication number | Publication date |
---|---|
NO900356D0 (no) | 1990-01-25 |
DK20290A (da) | 1990-01-25 |
EP0343993B1 (en) | 1992-05-13 |
FI900410A0 (fi) | 1990-01-25 |
NO179274B (no) | 1996-06-03 |
GB2220350B (en) | 1991-09-04 |
NO900356L (no) | 1990-01-25 |
US5108758A (en) | 1992-04-28 |
GB2220350A (en) | 1990-01-10 |
FI99085B (fi) | 1997-06-30 |
WO1989011269A1 (en) | 1989-11-30 |
ATE75936T1 (de) | 1992-05-15 |
NO179274C (no) | 1996-09-11 |
EP0343993A1 (en) | 1989-11-29 |
GB8812490D0 (en) | 1988-06-29 |
GB8912048D0 (en) | 1989-07-12 |
FI99085C (fi) | 1997-10-10 |
DE68901494D1 (de) | 1992-06-17 |
GR3004604T3 (ja) | 1993-04-28 |
CA1339081C (en) | 1997-07-29 |
JP2898036B2 (ja) | 1999-05-31 |
DK20290D0 (da) | 1990-01-25 |
DK175257B1 (da) | 2004-07-26 |
ES2037422T3 (es) | 1995-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH03505448A (ja) | 遅延放出性製剤 | |
RU2093148C1 (ru) | Композиции с замедленным (пролонгированным) высвобождением | |
JP4444496B2 (ja) | 低温コーティング | |
JP3665334B2 (ja) | 新規な医薬処方物 | |
DK174992B1 (da) | Farmaceutisk præparat med langsom frigivelse samt anvendelse af visse additiver i sådanne til opnåelse af langsom frigivelse | |
SU1410866A3 (ru) | Способ получени стеарата ацетилэритромицина | |
EP1613333A1 (en) | Oral extended release compressed tablets of multiparticulates | |
JPH05500668A (ja) | 制御放出組成物 | |
JP2001520986A (ja) | 放出制御処方 | |
JPH0441434A (ja) | 腸溶性コーティングを施した乳酸菌錠剤 | |
US4267138A (en) | Coating ensuring a controlled release of active ingredients of biologically active compositions, particularly pharmaceutical compositions and a process for preparation of biologically active compositions ensuring controlled release of active ingredients | |
WO1992015285A1 (en) | Starch-based controlled release compositions | |
US6514526B1 (en) | Coated starch capsules and a process for producing them | |
EP2046306B1 (en) | Coating composition comprising starch | |
AU671651B2 (en) | A drug delivery device and a method of making such device | |
JP4388607B2 (ja) | カゼイン硬カプセル及びその製造方法 | |
JPH08143463A (ja) | 腸内有用細菌含有錠剤 | |
Kajale et al. | Colon Targeted Drug Delivery System–A Review | |
Ahmed | Designing of Non-Steroidal Anti Inflammatory Biodegradable Drug Implants | |
CN101495104A (zh) | 含有淀粉的包衣组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080312 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090312 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 11 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100312 Year of fee payment: 11 |